Invention Application
- Patent Title: Antibody Molecules Which Bind IL-17A and IL-17F
-
Application No.: US15482260Application Date: 2017-04-07
-
Publication No.: US20170306052A1Publication Date: 2017-10-26
- Inventor: Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
- Applicant: UCB PHARMA S.A.
- Applicant Address: GB Slough
- Assignee: UCB PHARMA S.A.
- Current Assignee: UCB PHARMA S.A.
- Current Assignee Address: GB Slough
- Priority: GB0620729.4 20061018
- Main IPC: C07K16/46
- IPC: C07K16/46 ; A61K39/395 ; C07K16/24
Abstract:
The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Public/Granted literature
- US10308723B2 Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F Public/Granted day:2019-06-04
Information query
